Ginkgo Bioworks Holdings (DNA) Change in Account Payables (2020 - 2023)

Ginkgo Bioworks Holdings (DNA) has reported Change in Account Payables for 4 consecutive years, with -$6.7 million the latest figure, recorded in Q2 2023.

• For the quarter ending Q2 2023, Change in Account Payables rose 57.14% year-over-year to -$6.7 million; the trailing twelve-month figure through Jun 2023 stood at -$18.5 million (down 217.66% YoY), and the FY2025 full-year result was -$3.0 million, down 162.71% from the prior year.
• Change in Account Payables declined to -$6.7 million in Q2 2023 per DNA's latest filing, from $9.7 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $26.2 million in Q1 2022 and bottomed at -$15.6 million in Q2 2022.
• Historically, Change in Account Payables has averaged -$525363.6 across 4 years, with a median of $516000.0 in 2021.
• The widest YoY moves for Change in Account Payables: up 4987.21% in 2022, down 2912.4% in 2022.
• Over 4 years, Change in Account Payables stood at $4.3 million in 2020, then sank by 87.87% to $524000.0 in 2021, then plunged by 2912.4% to -$14.7 million in 2022, then surged by 54.63% to -$6.7 million in 2023.
• According to Business Quant data, Change in Account Payables over the past three periods registered -$6.7 million, $9.7 million, and -$14.7 million for Q2 2023, Q1 2023, and Q4 2022 respectively.